Mutations in DNA damage response genes, such as BRCA1 and BRCA2, observed in breast cancer are also associated with production of elevated mutation numbers, particularly of strong binder peptides to MHC molecules [39]. The gene discussed is BRCA2; the disease is breast cancer.